Clinical Trial

Single-Fraction Very Accelerated Partial Breast Irradiation (sfVAPBI)

Study acronym: sfVAPBI
Recruiting
View on ClinicalTrials.gov →
Summary
To investigate clinical outcomes, late side effects, and cosmetic results of a single-fraction very accelerated partial breast irradiation as postoperative local treatment for the treatment of early stage breast cancer.
Trial Details
NCT Number NCT07067437
Lead Sponsor National Institute of Oncology, Hungary
Conditions Breast Neoplasms
Enrollment 250 participants
Start Date 2025-07-01
Primary Completion 2027-07-01 (estimated)
Study Completion 2032-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-16